Melanie Sharp Moderating Panel at 13th Summit on Biosimilars and Innovator Biologics
June 29, 2022
Young Conaway's Commercial Litigation Chair and Partner, Melanie Sharp, will be moderating a panel at the American Conference Institute's 13th Summit on Biosimilars and Innovator Biologics held in Boston on June 29, 2022. The session entitled, "Advocating for Diversity in IP: Practical Ideas for Implementing Change," will focus on strategies members of the pharmaceutical IP community can apply in order to realize the full benefits of a diverse workforce. Ms. Sharp will be joined by esteemed panelists:
| Jason Murata Partner, Chair, Diversity, Equity & Inclusion Committee Axinn, Veltrop & Harkrider LLP |
Eldora L. Ellison, Ph.D. |
| K. Nicole Clouse IP Counsel Biogen |
Sarah Chapin Columbia Partner McDermott Will & Emery |
Hannah Lee |
To learn more, visit the Summit's website https://www.americanconference.com/biosimilars/agenda/.